Valuation Luye Pharma Group Ltd.

Equities

Market Closed - Hong Kong S.E. Other stock markets 09:08:05 13/09/2024 BST			5-day change	1st Jan Change
2.950 ^HKD	+0.68%		-3.28%	-20.91%

08-30	Citi Upgrades Luye Pharma to Buy From Sell; Price Target is HK$4	MT
08-28	Luye Pharma Group Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	CI

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	17,066	9,876	10,271	11,492	12,736	10,096	-	-
Change	-	-42.13%	4%	11.89%	10.83%	-20.73%	-	-
Enterprise Value (EV) ¹	19,944	15,885	16,935	15,564	15,712	12,298	12,193	11,428
Change	-	-20.35%	6.61%	-8.1%	0.95%	-21.73%	-0.85%	-6.28%
P/E ratio	11.4x	13.7x	-74.4x	18.6x	23.7x	12.7x	10.9x	8.84x
PBR	1.81x	1.23x	1.18x	1.11x	1.01x	0.72x	0.68x	0.63x
PEG	-	-0.3x	1x	-0x	-1.3x	0.3x	0.7x	0.4x
Capitalization / Revenue	2.68x	1.78x	1.98x	1.92x	2.07x	1.51x	1.34x	1.17x
EV / Revenue	3.14x	2.87x	3.26x	2.6x	2.56x	1.84x	1.62x	1.33x
EV / EBITDA	7.81x	8.46x	18.7x	8.59x	7.56x	6.3x	5.84x	4.77x
EV / EBIT	11.5x	16.5x	-2,609x	20.8x	18x	9.04x	8.4x	6.66x
EV / FCF	25,749,864x	46,634,506x	-45,302,911x	31,735,827x	-	-	-	-
FCF Yield	0%	0%	-0%	0%	-	-	-	-
Dividend per Share ²	0.113	-	-	-	-	-	-	-
Rate of return	2.16%	-	-	-	-	-	-	-
EPS ²	0.4584	0.2212	-0.039	0.1738	0.1429	0.212	0.2461	0.3037
Distribution rate	24.7%	-	-	-	-	-	-	-
Net sales ¹	6,358	5,540	5,200	5,982	6,143	6,682	7,538	8,623
EBITDA ¹	2,553	1,877	906.9	1,813	2,077	1,953	2,086	2,395
EBIT ¹	1,729	961.2	-6.49	747.6	872.9	1,360	1,451	1,716
Net income ¹	1,469	706.6	-134.4	604.8	532.6	784.7	1,016	1,257
Net Debt ¹	2,878	6,009	6,665	4,072	2,975	2,201	2,097	1,332
Reference price ²	5.221	3.040	2.900	3.237	3.386	2.684	2.684	2.684
Nbr of stocks (in thousands)	3,268,965	3,248,965	3,541,372	3,549,671	3,761,671	3,761,671	-	-
Announcement Date	26/03/20	31/03/21	29/03/22	29/03/23	27/03/24	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E ratio	EV / Sales	EV / EBITDA	Yield (Y)	Capi. ($)
LUYE PHARMA GROUP LTD.	12.66x	1.84x	6.3x	-.--%	1.42B
ELI LILLY AND COMPANY	59.56x	18.45x	44.86x	+0.56%	832B
NOVO NORDISK A/S	40.44x	14.09x	28.68x	+1.24%	605B
JOHNSON & JOHNSON	22.5x	4.58x	12.96x	+2.83%	398B
ABBVIE INC.	37.8x	7.16x	15.47x	+3.21%	343B
MERCK & CO., INC.	15.45x	4.91x	11.25x	+2.65%	294B
ROCHE HOLDING AG	15.86x	3.76x	9.85x	+3.71%	252B
ASTRAZENECA PLC	28.09x	5.05x	14.99x	+1.98%	243B
NOVARTIS AG	21.48x	4.95x	12.54x	+3.26%	234B
AMGEN INC.	51.21x	6.89x	12.07x	+2.76%	179B
Average	30.50x	7.17x	16.90x	+2.22%	338.15B
Weighted average by Cap.	37.11x	10.10x	23.56x	+2.04%